Praxis precision medicines to present at the piper sandler 35th annual healthcare conference

Boston, nov. 21, 2023 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in a fireside discussion at the piper sandler healthcare conference on november 28, 2023 at 10:00am. the event will be available via live webcast through the events & presentations page of the investors + media section of the company's website at www.praxismedicines.com.
PRAX Ratings Summary
PRAX Quant Ranking